Low-Molecular-Weight Heparin or Dual Antiplatelet Therapy Is More Effective Than Aspirin Alone in Preventing Early Neurological Deterioration and Improving the 6-Month Outcome in Ischemic Stroke Patients

BACKGROUND AND PURPOSE: Dual antiplatelet therapy (DAT) with clopidogrel and aspirin has been shown to confer greater protection against early neurological deterioration (END) and early recurrent ischemic stroke (ERIS) than aspirin alone in patients who have experienced an acute ischemic stroke. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Xingyang, Chi, Wanzhang, Wang, Chun, Zhang, Biao, Lin, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302180/
https://www.ncbi.nlm.nih.gov/pubmed/25628738
http://dx.doi.org/10.3988/jcn.2015.11.1.57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302180/
https://www.ncbi.nlm.nih.gov/pubmed/25628738
http://dx.doi.org/10.3988/jcn.2015.11.1.57

Ejemplares similares